BostonGene

BostonGene Corporation, founded in 2015 and headquartered in Boston, Massachusetts, U.S., is a biomedical software company dedicated to developing precise and personalized treatment solutions for cancer patients through cloud computing and artificial intelligence technologies. The company possesses a robust intellectual property portfolio and maintains close cooperative relationships with many cancer centers across the U.S. BostonGene's goal is to combine complex data analysis with scientific and clinical knowledge to assist physicians in selecting the optimal treatment strategies, thereby improving patient survival rates. The company was a pioneer in utilizing biomedical software for patient analysis and personalized medical decision-making, developing a biomedical information analysis platform based on cloud computing technology to achieve precision cancer treatment.